Filing metadata

Accession number
0001127602-25-012384
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Apr 21, 2025
Reporting period
Apr 17, 2025
Description
Insider transaction

Explore SEC Filings Hub